Walleye Trading’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-37,900
| Closed | -$346K | – | 4757 |
|
|
2025
Q2 | $346K | Buy |
+37,900
| New | +$279K | ﹤0.01% | 2906 |
|
|
2024
Q1 | – | Sell |
-10,800
| Closed | -$234K | – | 5266 |
|
|
2023
Q4 | $234K | Buy |
10,800
+7,100
| +192% | +$141K | ﹤0.01% | 3677 |
|
|
2023
Q3 | $76.1K | Sell |
3,700
-4,900
| -57% | -$142K | ﹤0.01% | 4083 |
|
|
2023
Q2 | $404K | Buy |
8,600
+4,500
| +110% | +$224K | ﹤0.01% | 2909 |
|
|
2023
Q1 | $172K | Sell |
4,100
-400
| -9% | -$17.2K | ﹤0.01% | 3606 |
|
|
2022
Q4 | $172K | Buy |
+4,500
| New | +$172K | ﹤0.01% | 3685 |
|
|
2021
Q4 | – | Sell |
-14,300
| Closed | -$634K | – | 5798 |
|
|
2021
Q3 | $634K | Buy |
14,300
+5,100
| +55% | +$234K | ﹤0.01% | 2702 |
|
|
2021
Q2 | $523K | Sell |
9,200
-5,000
| -35% | -$353K | ﹤0.01% | 2860 |
|
|
2021
Q1 | $1.06M | Buy |
14,200
+6,900
| +95% | +$566K | ﹤0.01% | 1863 |
|
|
2020
Q4 | $632K | Buy |
7,300
+2,000
| +38% | +$147K | ﹤0.01% | 2448 |
|
|
2020
Q3 | $324K | Sell |
5,300
-15,100
| -74% | -$765K | ﹤0.01% | 2610 |
|
|
2020
Q2 | $848K | Sell |
20,400
-4,000
| -16% | -$145K | 0.01% | 1815 |
|
|
2020
Q1 | $701K | Buy |
24,400
+17,000
| +230% | +$984K | 0.01% | 1578 |
|
|
2019
Q4 | $534K | Sell |
7,400
-8,200
| -53% | -$1.01M | ﹤0.01% | 2352 |
|
|
2019
Q3 | $2.19M | Buy |
15,600
+12,300
| +373% | +$2.06M | 0.02% | 961 |
|
|
2019
Q2 | $604K | Buy |
3,300
+1,800
| +120% | +$307K | 0.01% | 2040 |
|
|
2019
Q1 | $239K | Buy |
+1,500
| New | +$217K | ﹤0.01% | 2896 |
|
|
2018
Q4 | – | Sell |
-15,500
| Closed | -$2.19M | – | 5216 |
|
|
2018
Q3 | $2.19M | Buy |
+15,500
| New | +$2.39M | 0.01% | 1234 |
|
Other funds holding SAGE
Walleye Trading's SAGE Position: Q3 2025 in Review
Walleye Trading sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 42,376 shares — an estimated $386K sold.
Walleye Trading first reported a position in SAGE in Q4 2015 and held it in 9 quarters. The position peaked at $674K in Q3 2019. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.
- Walleye Trading reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
- Walleye Trading sold 42,376 Sage Therapeutics shares in Q3 2025, an estimated $386K.
- Walleye Trading first reported a position in Sage Therapeutics in Q4 2015 and held it in 9 quarters.
- Walleye Trading's Sage Therapeutics position peaked at $674K in Q3 2019.
- 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.
Based on Walleye Trading's 13F filing for Q3 2025, filed 14 Nov 2025.